http://streetinsider.com Latest StreetInsider.com News Articles en-us Copyright 2026, StreetInsider.com rss@streetinsider.com (SI RSS) rss@streetinsider.com (SI RSS) Thu, 18 Jun 2026 07:05:34 -0400 http://blogs.law.harvard.edu/tech/rss http://www.streetinsider.com/images/rss_logo.gif http://streetinsider.com 143 28 0 1 2 3 21 22 23 Saturday Sunday http://www.streetinsider.com/Corporate+News/CareDx+to+present+30%2B+abstracts+at+2026+American+Transplant+Congress/26662707.html <p>CareDx, Inc. (Nasdaq: CDNA) announced it will present data from more than 30 abstracts and nine oral presentations at the American Transplant Congress (ATC) 2026, scheduled for June 20–24 in Boston, Massachusetts.</p><p>The presentations will cover findings related to AlloSure Kidney, AlloSure Plus, HistoMap Kidney, HeartCare, AlloMap Heart, AlloSure Heart, and AlloSure Lung, drawing on studies conducted at more than 110 transplant centers across the United States.</p><p>According to the company, data from the studies show AlloSure donor-derived cell-free DNA is being evaluated as a potential clinical endpoint for assessing allograft injury, monitoring treatment response, and evaluating long-term graft health in kidney http://www.streetinsider.com/Corporate+News/CareDx+to+present+30%2B+abstracts+at+2026+American+Transplant+Congress/26662707.html Thu, 18 Jun 2026 07:05:34 -0400 CDNA http://www.streetinsider.com/Press+Releases/CareDx+Precision+Medicine+Diagnostics+Showcased+in+Over+30+Abstracts+and+9+Oral+Presentations+at+the+2026+American+Transplant+Congress/26662704.html <p> <i>Growing body of evidence supports AlloSure</i>®<i> as a clinical endpoint for risk assessment, treatment response, and long-term graft outcomes</i> </p><p> <i>Data across kidney, heart, lung, and multi-organ transplantation; featuring new KOAR prognostic findings and ImmuneScape™ single cell and spatial transcriptomics rejection classification advances</i> </p> <p> BRISBANE, Calif.--(BUSINESS WIRE)-- CareDx, Inc. (Nasdaq: CDNA) — The Transplant Company™, a leading precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high‑value healthcare solutions for transplant patients and caregivers, today announced its participation at the American Transplant Congress (ATC) 2026, taking place June 20–24 in Boston, Massachusetts. </p><p> Real-world clinical use and scientific advancements http://www.streetinsider.com/Press+Releases/CareDx+Precision+Medicine+Diagnostics+Showcased+in+Over+30+Abstracts+and+9+Oral+Presentations+at+the+2026+American+Transplant+Congress/26662704.html Thu, 18 Jun 2026 07:05:00 -0400 A.50213484 CDNA O.00767124 O.29765439 http://www.streetinsider.com/Press+Releases/CareDx+Precision+Medicine+Diagnostics+Showcased+in+Over+30+Abstracts+and+9+Oral+Presentations+at+the+2026+American+Transplant+Congress/26662704.html <p> <i>Growing body of evidence supports AlloSure</i>®<i> as a clinical endpoint for risk assessment, treatment response, and long-term graft outcomes</i> </p><p> <i>Data across kidney, heart, lung, and multi-organ transplantation; featuring new KOAR prognostic findings and ImmuneScape™ single cell and spatial transcriptomics rejection classification advances</i> </p> <p> BRISBANE, Calif.--(BUSINESS WIRE)-- CareDx, Inc. (Nasdaq: CDNA) — The Transplant Company™, a leading precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high‑value healthcare solutions for transplant patients and caregivers, today announced its participation at the American Transplant Congress (ATC) 2026, taking place June 20–24 in Boston, Massachusetts. </p><p> Real-world clinical use and scientific advancements http://www.streetinsider.com/Press+Releases/CareDx+Precision+Medicine+Diagnostics+Showcased+in+Over+30+Abstracts+and+9+Oral+Presentations+at+the+2026+American+Transplant+Congress/26662704.html Thu, 18 Jun 2026 07:05:00 -0400 A.50213484 CDNA O.00767124 O.29765439 http://www.streetinsider.com/Press+Releases/CareDx+Precision+Medicine+Diagnostics+Showcased+in+Over+30+Abstracts+and+9+Oral+Presentations+at+the+2026+American+Transplant+Congress/26662704.html <p> <i>Growing body of evidence supports AlloSure</i>®<i> as a clinical endpoint for risk assessment, treatment response, and long-term graft outcomes</i> </p><p> <i>Data across kidney, heart, lung, and multi-organ transplantation; featuring new KOAR prognostic findings and ImmuneScape™ single cell and spatial transcriptomics rejection classification advances</i> </p> <p> BRISBANE, Calif.--(BUSINESS WIRE)-- CareDx, Inc. (Nasdaq: CDNA) — The Transplant Company™, a leading precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high‑value healthcare solutions for transplant patients and caregivers, today announced its participation at the American Transplant Congress (ATC) 2026, taking place June 20–24 in Boston, Massachusetts. </p><p> Real-world clinical use and scientific advancements http://www.streetinsider.com/Press+Releases/CareDx+Precision+Medicine+Diagnostics+Showcased+in+Over+30+Abstracts+and+9+Oral+Presentations+at+the+2026+American+Transplant+Congress/26662704.html Thu, 18 Jun 2026 07:05:00 -0400 A.50213484 CDNA O.00767124 O.29765439 http://www.streetinsider.com/Press+Releases/CareDx+Precision+Medicine+Diagnostics+Showcased+in+Over+30+Abstracts+and+9+Oral+Presentations+at+the+2026+American+Transplant+Congress/26662704.html <p> <i>Growing body of evidence supports AlloSure</i>®<i> as a clinical endpoint for risk assessment, treatment response, and long-term graft outcomes</i> </p><p> <i>Data across kidney, heart, lung, and multi-organ transplantation; featuring new KOAR prognostic findings and ImmuneScape™ single cell and spatial transcriptomics rejection classification advances</i> </p> <p> BRISBANE, Calif.--(BUSINESS WIRE)-- CareDx, Inc. (Nasdaq: CDNA) — The Transplant Company™, a leading precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high‑value healthcare solutions for transplant patients and caregivers, today announced its participation at the American Transplant Congress (ATC) 2026, taking place June 20–24 in Boston, Massachusetts. </p><p> Real-world clinical use and scientific advancements http://www.streetinsider.com/Press+Releases/CareDx+Precision+Medicine+Diagnostics+Showcased+in+Over+30+Abstracts+and+9+Oral+Presentations+at+the+2026+American+Transplant+Congress/26662704.html Thu, 18 Jun 2026 07:05:00 -0400 A.50213484 CDNA O.00767124 O.29765439 http://www.streetinsider.com/Business+Wire/CareDx+Precision+Medicine+Diagnostics+Showcased+in+Over+30+Abstracts+and+9+Oral+Presentations+at+the+2026+American+Transplant+Congress/26662704.html <p> <i>Growing body of evidence supports AlloSure</i>®<i> as a clinical endpoint for risk assessment, treatment response, and long-term graft outcomes</i> </p><p> <i>Data across kidney, heart, lung, and multi-organ transplantation; featuring new KOAR prognostic findings and ImmuneScape™ single cell and spatial transcriptomics rejection classification advances</i> </p> <p> BRISBANE, Calif.--(BUSINESS WIRE)-- CareDx, Inc. (Nasdaq: CDNA) — The Transplant Company™, a leading precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high‑value healthcare solutions for transplant patients and caregivers, today announced its participation at the American Transplant Congress (ATC) 2026, taking place June 20–24 in Boston, Massachusetts. </p><p> Real-world clinical use and scientific advancements http://www.streetinsider.com/Business+Wire/CareDx+Precision+Medicine+Diagnostics+Showcased+in+Over+30+Abstracts+and+9+Oral+Presentations+at+the+2026+American+Transplant+Congress/26662704.html Thu, 18 Jun 2026 07:05:00 -0400 A.50213484 CDNA O.00767124 O.29765439 http://www.streetinsider.com/Business+Wire/CareDx+Precision+Medicine+Diagnostics+Showcased+in+Over+30+Abstracts+and+9+Oral+Presentations+at+the+2026+American+Transplant+Congress/26662704.html <p> <i>Growing body of evidence supports AlloSure</i>®<i> as a clinical endpoint for risk assessment, treatment response, and long-term graft outcomes</i> </p><p> <i>Data across kidney, heart, lung, and multi-organ transplantation; featuring new KOAR prognostic findings and ImmuneScape™ single cell and spatial transcriptomics rejection classification advances</i> </p> <p> BRISBANE, Calif.--(BUSINESS WIRE)-- CareDx, Inc. (Nasdaq: CDNA) — The Transplant Company™, a leading precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high‑value healthcare solutions for transplant patients and caregivers, today announced its participation at the American Transplant Congress (ATC) 2026, taking place June 20–24 in Boston, Massachusetts. </p><p> Real-world clinical use and scientific advancements http://www.streetinsider.com/Business+Wire/CareDx+Precision+Medicine+Diagnostics+Showcased+in+Over+30+Abstracts+and+9+Oral+Presentations+at+the+2026+American+Transplant+Congress/26662704.html Thu, 18 Jun 2026 07:05:00 -0400 A.50213484 CDNA O.00767124 O.29765439 http://www.streetinsider.com/Business+Wire/CareDx+Precision+Medicine+Diagnostics+Showcased+in+Over+30+Abstracts+and+9+Oral+Presentations+at+the+2026+American+Transplant+Congress/26662704.html <p> <i>Growing body of evidence supports AlloSure</i>®<i> as a clinical endpoint for risk assessment, treatment response, and long-term graft outcomes</i> </p><p> <i>Data across kidney, heart, lung, and multi-organ transplantation; featuring new KOAR prognostic findings and ImmuneScape™ single cell and spatial transcriptomics rejection classification advances</i> </p> <p> BRISBANE, Calif.--(BUSINESS WIRE)-- CareDx, Inc. (Nasdaq: CDNA) — The Transplant Company™, a leading precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high‑value healthcare solutions for transplant patients and caregivers, today announced its participation at the American Transplant Congress (ATC) 2026, taking place June 20–24 in Boston, Massachusetts. </p><p> Real-world clinical use and scientific advancements http://www.streetinsider.com/Business+Wire/CareDx+Precision+Medicine+Diagnostics+Showcased+in+Over+30+Abstracts+and+9+Oral+Presentations+at+the+2026+American+Transplant+Congress/26662704.html Thu, 18 Jun 2026 07:05:00 -0400 A.50213484 CDNA O.00767124 O.29765439 http://www.streetinsider.com/Business+Wire/CareDx+Precision+Medicine+Diagnostics+Showcased+in+Over+30+Abstracts+and+9+Oral+Presentations+at+the+2026+American+Transplant+Congress/26662704.html <p> <i>Growing body of evidence supports AlloSure</i>®<i> as a clinical endpoint for risk assessment, treatment response, and long-term graft outcomes</i> </p><p> <i>Data across kidney, heart, lung, and multi-organ transplantation; featuring new KOAR prognostic findings and ImmuneScape™ single cell and spatial transcriptomics rejection classification advances</i> </p> <p> BRISBANE, Calif.--(BUSINESS WIRE)-- CareDx, Inc. (Nasdaq: CDNA) — The Transplant Company™, a leading precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high‑value healthcare solutions for transplant patients and caregivers, today announced its participation at the American Transplant Congress (ATC) 2026, taking place June 20–24 in Boston, Massachusetts. </p><p> Real-world clinical use and scientific advancements http://www.streetinsider.com/Business+Wire/CareDx+Precision+Medicine+Diagnostics+Showcased+in+Over+30+Abstracts+and+9+Oral+Presentations+at+the+2026+American+Transplant+Congress/26662704.html Thu, 18 Jun 2026 07:05:00 -0400 A.50213484 CDNA O.00767124 O.29765439 http://www.streetinsider.com/SEC+Filings/Form++4++++++++++CareDx%2C+Inc.++++++++++++++For%3A+Jun+15++Filed+by%3A+Hanna+John+Walter+JR/26659861.html si-local-file:///var/storage/secattach/20260617/26659861.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++CareDx%2C+Inc.++++++++++++++For%3A+Jun+15++Filed+by%3A+Hanna+John+Walter+JR/26659861.html Wed, 17 Jun 2026 16:06:00 -0400 CDNA O.00767124 http://www.streetinsider.com/SEC+Filings/Form++4++++++++++CareDx%2C+Inc.++++++++++++++For%3A+Jun+15++Filed+by%3A+Hanna+John+Walter+JR/26659861.html si-local-file:///var/storage/secattach/20260617/26659861.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++CareDx%2C+Inc.++++++++++++++For%3A+Jun+15++Filed+by%3A+Hanna+John+Walter+JR/26659861.html Wed, 17 Jun 2026 16:06:00 -0400 CDNA O.00767124 http://www.streetinsider.com/SEC+Filings/Form++4++++++++++CareDx%2C+Inc.++++++++++++++For%3A+Jun+12++Filed+by%3A+COURNOYER+CHRISTINE/26655464.html si-local-file:///var/storage/secattach/20260616/26655464.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++CareDx%2C+Inc.++++++++++++++For%3A+Jun+12++Filed+by%3A+COURNOYER+CHRISTINE/26655464.html Tue, 16 Jun 2026 17:51:00 -0400 CDNA O.00767124 http://www.streetinsider.com/SEC+Filings/Form++4++++++++++CareDx%2C+Inc.++++++++++++++For%3A+Jun+12++Filed+by%3A+COURNOYER+CHRISTINE/26655464.html si-local-file:///var/storage/secattach/20260616/26655464.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++CareDx%2C+Inc.++++++++++++++For%3A+Jun+12++Filed+by%3A+COURNOYER+CHRISTINE/26655464.html Tue, 16 Jun 2026 17:51:00 -0400 CDNA O.00767124 http://www.streetinsider.com/SEC+Filings/Form++4++++++++++CareDx%2C+Inc.++++++++++++++For%3A+Jun+12++Filed+by%3A+Valantine+Hannah/26655465.html si-local-file:///var/storage/secattach/20260616/26655465.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++CareDx%2C+Inc.++++++++++++++For%3A+Jun+12++Filed+by%3A+Valantine+Hannah/26655465.html Tue, 16 Jun 2026 17:51:00 -0400 CDNA O.00767124 http://www.streetinsider.com/SEC+Filings/Form++4++++++++++CareDx%2C+Inc.++++++++++++++For%3A+Jun+12++Filed+by%3A+Valantine+Hannah/26655465.html si-local-file:///var/storage/secattach/20260616/26655465.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++CareDx%2C+Inc.++++++++++++++For%3A+Jun+12++Filed+by%3A+Valantine+Hannah/26655465.html Tue, 16 Jun 2026 17:51:00 -0400 CDNA O.00767124 http://www.streetinsider.com/SEC+Filings/Form++4++++++++++CareDx%2C+Inc.++++++++++++++For%3A+Jun+12++Filed+by%3A+Cohen+Fred+E/26655456.html si-local-file:///var/storage/secattach/20260616/26655456.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++CareDx%2C+Inc.++++++++++++++For%3A+Jun+12++Filed+by%3A+Cohen+Fred+E/26655456.html Tue, 16 Jun 2026 17:50:00 -0400 CDNA O.00767124 http://www.streetinsider.com/SEC+Filings/Form++4++++++++++CareDx%2C+Inc.++++++++++++++For%3A+Jun+12++Filed+by%3A+Cohen+Fred+E/26655456.html si-local-file:///var/storage/secattach/20260616/26655456.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++CareDx%2C+Inc.++++++++++++++For%3A+Jun+12++Filed+by%3A+Cohen+Fred+E/26655456.html Tue, 16 Jun 2026 17:50:00 -0400 CDNA O.00767124 http://www.streetinsider.com/SEC+Filings/Form++4++++++++++CareDx%2C+Inc.++++++++++++++For%3A+Jun+12++Filed+by%3A+Riggsbee+Richard+Bryan/26655461.html si-local-file:///var/storage/secattach/20260616/26655461.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++CareDx%2C+Inc.++++++++++++++For%3A+Jun+12++Filed+by%3A+Riggsbee+Richard+Bryan/26655461.html Tue, 16 Jun 2026 17:50:00 -0400 CDNA O.00767124 http://www.streetinsider.com/SEC+Filings/Form++4++++++++++CareDx%2C+Inc.++++++++++++++For%3A+Jun+12++Filed+by%3A+Riggsbee+Richard+Bryan/26655461.html si-local-file:///var/storage/secattach/20260616/26655461.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++CareDx%2C+Inc.++++++++++++++For%3A+Jun+12++Filed+by%3A+Riggsbee+Richard+Bryan/26655461.html Tue, 16 Jun 2026 17:50:00 -0400 CDNA O.00767124 http://www.streetinsider.com/SEC+Filings/Form++4++++++++++CareDx%2C+Inc.++++++++++++++For%3A+Jun+12++Filed+by%3A+Gunasekaran+Suresh/26655451.html si-local-file:///var/storage/secattach/20260616/26655451.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++CareDx%2C+Inc.++++++++++++++For%3A+Jun+12++Filed+by%3A+Gunasekaran+Suresh/26655451.html Tue, 16 Jun 2026 17:49:00 -0400 CDNA O.00767124 http://www.streetinsider.com/SEC+Filings/Form++4++++++++++CareDx%2C+Inc.++++++++++++++For%3A+Jun+12++Filed+by%3A+Gunasekaran+Suresh/26655451.html si-local-file:///var/storage/secattach/20260616/26655451.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++CareDx%2C+Inc.++++++++++++++For%3A+Jun+12++Filed+by%3A+Gunasekaran+Suresh/26655451.html Tue, 16 Jun 2026 17:49:00 -0400 CDNA O.00767124 http://www.streetinsider.com/SEC+Filings/Form++4++++++++++CareDx%2C+Inc.++++++++++++++For%3A+Jun+12++Filed+by%3A+Goldberg+Michael/26655447.html si-local-file:///var/storage/secattach/20260616/26655447.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++CareDx%2C+Inc.++++++++++++++For%3A+Jun+12++Filed+by%3A+Goldberg+Michael/26655447.html Tue, 16 Jun 2026 17:48:00 -0400 CDNA O.00767124 http://www.streetinsider.com/SEC+Filings/Form++4++++++++++CareDx%2C+Inc.++++++++++++++For%3A+Jun+12++Filed+by%3A+Goldberg+Michael/26655447.html si-local-file:///var/storage/secattach/20260616/26655447.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++CareDx%2C+Inc.++++++++++++++For%3A+Jun+12++Filed+by%3A+Goldberg+Michael/26655447.html Tue, 16 Jun 2026 17:48:00 -0400 CDNA O.00767124 http://www.streetinsider.com/SEC+Filings/Form++4++++++++++CareDx%2C+Inc.++++++++++++++For%3A+Jun+12++Filed+by%3A+Bickerstaff+George/26655449.html si-local-file:///var/storage/secattach/20260616/26655449.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++CareDx%2C+Inc.++++++++++++++For%3A+Jun+12++Filed+by%3A+Bickerstaff+George/26655449.html Tue, 16 Jun 2026 17:48:00 -0400 CDNA O.00767124 http://www.streetinsider.com/SEC+Filings/Form++4++++++++++CareDx%2C+Inc.++++++++++++++For%3A+Jun+12++Filed+by%3A+Bickerstaff+George/26655449.html si-local-file:///var/storage/secattach/20260616/26655449.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++CareDx%2C+Inc.++++++++++++++For%3A+Jun+12++Filed+by%3A+Bickerstaff+George/26655449.html Tue, 16 Jun 2026 17:48:00 -0400 CDNA O.00767124